Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.
Saved in:
| Title: | Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors. |
|---|---|
| Authors: | Nelson BE; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Janku F; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Fu S; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Dumbrava EE; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Hong DS; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Karp DD; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Naing A; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Rodon J; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Tsimberidou AM; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Murthy R; Department of Interventional Radiology, U.T. M.D. Anderson Cancer Center, Houston, Texas., Sheth RA; Department of Interventional Radiology, U.T. M.D. Anderson Cancer Center, Houston, Texas., Amaria RN; Department of Melanoma Medical Oncology, U.T. M.D. Anderson Cancer Center, Houston, Texas., Conley AP; Department of Sarcoma Medical Oncology, U.T. M.D. Anderson Cancer Center, Houston, Texas., Damodaran S; Department of Breast Medical Oncology, U.T. M.D. Anderson Cancer Center, Houston, Texas., Raghav KPS; Department of Gastrointestinal Medical Oncology, U.T. M.D. Anderson Cancer Center, Houston, Texas., Carapanceanu N; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Singh MP; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Carapanceanu V; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Pezeshki A; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Leontovich AA; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Kreider BL; Biomed Valley Discoveries, Kansas City, Missouri., Tung D; Biomed Valley Discoveries, Kansas City, Missouri., Varterasian M; Biomed Valley Discoveries, Kansas City, Missouri., Khazaie K; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Piha-Paul SA; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Sep 15; Vol. 31 (18), pp. 3864-3875. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
